Endometriosis is an enigmatic condition that affects millions of women worldwide. It is defined as the presence of functioning, endometrial-like tissue outside the uterus, which often induces a chronic, inflammatory reaction. It is predominantly found in women of reproductive age, from all ethnic and social groups. The associated symptoms - dysmenorrhea, chronic pelvic pain, dyspareunia, pain on micturition/defaecation, and sub-fertility - impact on a woman’s general physical, mental and social well being.
The aim of this meeting is to achieve a consensus regarding the most appropriate entry criteria, outcomes and measurement tools for clinical studies assessing treatments for endometriosis associated pain. The participants will be a) clinicians and scientists in the fields of chronic pelvic pain, endometriosis and pain in general, and b) representatives from the pharmaceutical industry, American Society of Reproductive Medicine, FDA and patient advocacy groups.
Sponsored by:
National Institute of Child Health and Human Development 
